ASAdonis Sotoodeh

Adonis Sotoodeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adonis Sotoodeh has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Socioeconomic factors and non-admission to the intensive care unit decisions in hospitalised COVID-19 patients: a retrospective cohort study in Stockholm, Sweden

    by Adonis Sotoodeh, Pontus Hedberg, Johan Zetterqvist, Johan Mårtensson, Pontus Naucler

    Objective: To investigate the association between socioeconomic factors (education level, region of birth and household composition) and non-admission to the intensive care unit (ICU) decisions in patients hospitalised with COVID-19. Design: Retrospective multicentre cohort study using linkage of several population-based health registries. Setting: Five acute care hospitals in Region Stockholm, Sweden, between March 2020 and February 2023. Participants: Data were extracted from 20 764 patients aged ≥18 years hospitalised with COVID-19. Main outcome measure: A recorded decision of non-admission to the ICU within 72 hours of admission. We used a modified Poisson regression model for each socioeconomic factor separately, adjusting for the other socioeconomic factors, age, sex, comorbidities, care services, calendar time, hospital and ICU occupancy. Results: Among 20 764 individuals, 2823 (13.6%) received a non-admission to the ICU decision. In the adjusted model, completion of primary or secondary education as the highest level was associated with an increased risk of receiving a decision of non-admission to the ICU (adjusted risk ratio (aRR) 1.20 (95% CI 1.10 to 1.30, p<0.01) and aRR 1.14 (95% CI 1.05 to 1.23, p<0.01), respectively) compared with completion of tertiary education. Being born in Northwestern Europe and Northern America, as opposed to Sweden specifically, was also associated with an increased risk (aRR 1.15 (95% CI 1.06 to 1.26, p<0.01)). Conclusion: We observed an increased risk of receiving a non-admission to the ICU decision for patients with lower levels of education and those born in Northwestern Europe or Northern America. This calls for action by physicians and policymakers to address socioeconomic inequities in access to intensive care.

  • Open Access

    Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis

    by Adonis Sotoodeh, Madeleine Nguyen Hoang, Karin Hellgren, Anders Forss

    Background There is some evidence of a higher prevalence of coeliac disease (CD) among patients with SLE than in the general population. However, the prevalence estimates vary substantially. Objective To investigate the prevalence of CD among patients with SLE through systematic review and meta-analysis. Methods We performed searches in the databases of Medline, Embase, Cochrane and Web of Science Core Collection between 1 January 1990 and 9 July 2023. A total of 2053 publications were rendered in the searches, of which 68 were reviewed in full text and 14 included in the analyses. Primary analysis estimated the pooled prevalence of biopsy-verified CD in patients with SLE. In the secondary analysis, the prevalence of serological markers indicative of CD was investigated. The quality of studies was appraised using the Joanna Briggs Institute Critical Appraisal Tool. We conducted meta-regression analyses to investigate associations between the prevalence of CD in individuals with SLE and publication year, study population size, CD prevalence in the general population, proportion of females and quality assessment score. Results A total of 14 studies met the inclusion criteria, of which 11 were included in the primary analysis of biopsy-verified CD. Among 1238 patients with SLE, 14 had CD. The weighted pooled prevalence of CD was 0.7% (95% CI 0.0 to 1.8). The weighted pooled prevalence of CD serological markers in 1063 patients with SLE was 3.7% (95% CI 1.4 to 6.7). In meta-regression analyses, no associations between CD prevalence and study characteristics, demographics and quality assessment scores were found. Conclusions In this meta-analysis, we found a weighted pooled prevalence of biopsy-verified CD in patients with SLE comparable with the prevalence in the general population. Our findings do not support routine screening for CD in patients with SLE. However, individual screening could be considered in cases of clinical suspicion and additional risk factors for CD. PROSPERO registration number CRD42022339594.